Joseph Thome
Stock Analyst at TD Cowen
(0.57)
# 4,071
Out of 4,989 analysts
17
Total ratings
35.71%
Success rate
-16.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Initiates: Buy | $95 | $73.61 | +29.06% | 1 | Sep 24, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Buy | n/a | $50.85 | - | 1 | May 13, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | n/a | $19.23 | - | 1 | Nov 25, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $350 → $400 | $425.01 | -5.88% | 2 | Oct 21, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | n/a | $25.83 | - | 1 | Jul 2, 2024 | |
| ALKS Alkermes | Initiates: Buy | $34 | $27.28 | +24.63% | 1 | Jun 17, 2024 | |
| PRME Prime Medicine | Initiates: Buy | n/a | $5.27 | - | 1 | Apr 8, 2024 | |
| MGX Metagenomi | Initiates: Outperform | n/a | $2.12 | - | 1 | Mar 5, 2024 | |
| PTCT PTC Therapeutics | Maintains: Market Perform | $32 → $30 | $58.30 | -48.54% | 2 | Mar 1, 2024 | |
| XENE Xenon Pharmaceuticals | Initiates: Outperform | n/a | $36.59 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.56 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $130 | $117.37 | +10.77% | 2 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $17.00 | - | 1 | Jan 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.54 | - | 1 | Nov 23, 2021 |
Mirum Pharmaceuticals
Sep 24, 2025
Initiates: Buy
Price Target: $95
Current: $73.61
Upside: +29.06%
Bright Minds Biosciences
May 13, 2025
Initiates: Buy
Price Target: n/a
Current: $50.85
Upside: -
Viridian Therapeutics
Nov 25, 2024
Initiates: Buy
Price Target: n/a
Current: $19.23
Upside: -
United Therapeutics
Oct 21, 2024
Maintains: Buy
Price Target: $350 → $400
Current: $425.01
Upside: -5.88%
Rapport Therapeutics
Jul 2, 2024
Initiates: Buy
Price Target: n/a
Current: $25.83
Upside: -
Alkermes
Jun 17, 2024
Initiates: Buy
Price Target: $34
Current: $27.28
Upside: +24.63%
Prime Medicine
Apr 8, 2024
Initiates: Buy
Price Target: n/a
Current: $5.27
Upside: -
Metagenomi
Mar 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.12
Upside: -
PTC Therapeutics
Mar 1, 2024
Maintains: Market Perform
Price Target: $32 → $30
Current: $58.30
Upside: -48.54%
Xenon Pharmaceuticals
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $36.59
Upside: -
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.56
Upside: -
Jun 29, 2022
Maintains: Outperform
Price Target: $120 → $130
Current: $117.37
Upside: +10.77%
Jan 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $17.00
Upside: -
Nov 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.54
Upside: -